A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer

Gastric Cancer

Volumn 15, Issue SUPPL.1, 2012, Pages

  Brar, Savtaj S ^a,b   Seevaratnam, Rajini ^c   Cardoso, Roberta ^c   Law, Calvin ^a   Helyer, Lucy ^d   Coburn, Natalie ^a,c  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^c Sunnybrook Health Sciences Centre   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Gastric cancer; Lymphadenectomy; Pancreas; Spleen; Surgery

Indexed keywords

ANASTOMOSIS LEAKAGE; CANCER SURVIVAL; GASTRECTOMY; HUMAN; LYMPH NODE DISSECTION; META ANALYSIS; OVERALL SURVIVAL; PANCREAS FISTULA; PANCREAS RESECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; SPLENECTOMY; STOMACH CANCER; SURGICAL MORTALITY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; METHODOLOGY; MORTALITY; PANCREAS; PATHOLOGY; PROGNOSIS; SPLEEN; STOMACH TUMOR; SURVIVAL RATE;

HUMANS; LYMPH NODE EXCISION; PANCREAS; PANCREATECTOMY; PROGNOSIS; SPLEEN; SPLENECTOMY; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84873478878     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-011-0087-4     Document Type: Review

References (52)

1. Bonenkamp J, Songun I, Welvaart K, van de Velde C, Hermans J, Sasako M, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345:745-8.
2. Cuschieri A, Joypaul V, Fayers P, Cook P, Fielding J, Craven J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet. 1996;347:995-9.
3. McCulloch P, Niita ME, Kazi H, Gama Rodrigues J. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg. 2005;92:5-13.
4. Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg. 2011;253:900.
5. Tanizawa Y, Terashima M. Lymph node dissection in the resection of gastric cancer: review of existing evidence. Gastric Cancer. 2010;13:137-48.
6. Yang SH, Zhang YC, Yang KH, Li YP, He XD, Tian JH, et al. An evidence-based medicine review of lymphadenectomy extent for gastric cancer. Am J Surg. 2009;197:246-51.
7. Huang CM, Wang JB, Lu HS, Zheng CH, Li P, Xie JW, et al. Prognostic impact of splenectomy on advanced proximal gastric cancer with No. 10 lymph node metastasis. Chin Med J. 2009;122:2757-62.
8. Chikara K, Hiroshi S, Masato N, Hirotoshi A, Goro M, Hidetaka O. Indications for pancreaticosplenectomy in advanced gastric cancer. Hepatogastroenterology. 2001;48:908-12.
9. Kodera Y, Sasako M, Yamamoto S, Sano T, Nashimoto A, Kurita A. Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg. 2005;92:1103-9.
10. Yonemura Y, Wu CC, Fukushima N, Honda I, Bandou E, Kawamura T, et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol. 2008;13:132-7.
11. Otsuji E, Yamaguchi T, Sawai K, Okamoto K, Takahashi T. Total gastrectomy with simultaneous pancreaticosplenectomy or splenectomy in patients with advanced gastric carcinoma. Br J Cancer. 1999;79:1789.
12. Erturk S, Ersan Y, Cicek Y, Dogusoy G, Senocak M. Effect of simultaneous splenectomy on the survival of patients undergoing curative gastrectomy for proximal gastric carcinoma. Surg Today. 2003;33:254-8.
13. Saka M, Morita S, Fukagawa T, Katai H. Present and future status of gastric cancer surgery. Jpn J Clin Oncol. 2011;41:307.
14. Kasakura Y, Fujii M, Mochizuki F, Kochi M, Kaiga T. Is there a benefit of pancreaticosplenectomy with gastrectomy for advanced gastric cancer? Am J Surg. 2000;179:237-42.
15. Noguchi Y, Yamamoto Y, Morinaga S, Amano T, Yoshikawa T, Tsuburaya A, et al. Does pancreaticosplenectomy contribute to better survival? Hepatogastroenterology. 2002;49:1436-40.
16. Schmid A, Thybusch A, Kremer B, Henne-Bruns D. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients. Hepatogastroenterology. 2000;47:579-85.
17. Takeuchi K, Tsuzuki Y, Ando T, Sekihara M, Hara T, Yoshikawa M, et al. Total gastrectomy with distal pancreatectomy and splenectomy for advanced gastric cancer. J Surg Res. 2001;101:196-201.
18. Yamamoto M, Baba H, Kakeji Y, Endo K, Ikeda Y, Toh Y, et al. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer. Hepatogastroenterology. 2001;51:298-302.
19. Ohno M, Nakamura T, Ajiki T, Horiuchi H, Tabuchi Y, Kuroda Y. Procedure for lymph node dissection around splenic artery in proximal gastric cancer. Hepatogastroenterology. 2003;50:1173-7.
20. Sakaguchi T, Sawada H, Yamada Y, Fujimoto H, Emoto K, Takayama T, et al. Indication of splenectomy for gastric carcinoma involving the proximal part of the stomach. Hepatogastroenterology. 2001;48:603-5.
21. Kitamura K, Nishida S, Ichikawa D, Taniguchi H, Hagiwara A, Yamaguchi T, et al. No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer. Br J Surg. 1999;86:119-22.
22. Sasada S, Ninomiya M, Nishizaki M, Harano M, Ojima Y, Matsukawa H, et al. Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer. Anticancer Res. 2009;29:3347.
23. Wang JY, Huang TJ, Chen FM, Huang CJ, Huang YS, Hsieh JS. A comparative study of pancreatectomy and pancreas-preserving gastrectomy in advanced gastric carcinomas. Hepatogastroenterology. 2004;51:1229-32.
24. Songun I, Putter H, Kranenbarg EMK, Sasako M, van de Velde CJH. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439-49.
25. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, et al. Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer. 1999;79:1522.
26. Csendes A, Burdiles P, Rojas J, Braghetto I, Diaz JC, Maluenda F. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery. 2002;131:401-7.
27. Furukawa H, Hiratsuka M, Ishikawa O, Ikeda M, Imamura H, Masutani S, et al. Total gastrectomy with dissection of lymph nodes along the splenic artery: a pancreas-preserving method. Ann Surg Oncol. 2000;7:669-73.
28. Yu W, Choi G, Chung H. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg. 2006;93:559-63.
29. Fatouros M, Roukos DH, Lorenz M, Arampatzis I, Hottentrott C, Encke A, et al. Impact of spleen preservation in patients with gastric cancer. Anticancer Res. 2005;25:3023.
30. Okinaga K, Iinuma H, Kitamura Y, Yokohata T, Inaba T, Fukushima R. Effect of immunotherapy and spleen preservation on immunological function in patients with gastric cancer. J Exp Clin Cancer Res. 2006;25:341.
31. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011;14:113-123.
32. Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol (EJSO). 2004;30:303-8.
33. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
34. Edwards P, Blackshaw G, Lewis W, Barry J, Allison M, Jones D. Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer. 2004;90:1888-92.
35. Wu C, Hsiung C, Lo S, Hsieh M, Shia L, Whang Peng J. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg. 2004;91:283-7.
36. Gorbunov E, Wechsler J, Stašek T, Tomin A, Solodun L. Significant prognostic factors in 283 patients after surgery for adenocarcinoma of the stomach. Scripta Medica (Brno). 2005;78:3-16.
37. Qin H, Lin C. Radical resection of gastric carcinoma with pancreas and spleen preservation a nd functional cleaning of lymph nodes. Chin Med J. 2002;115:736-9.
38. Kikuchi S, Nemoto Y, Natsuya K, Sakuramoto S, Kobayashi N, Shimao H, et al. Which patients with advanced, proximal gastric cancer benefit from complete clearance of spleno-pancreatic lymph nodes? Anticancer Res. 2002;22:3513-7.
39. Lee KY, Noh SH, Hyung WJ, Lee JH, Lah KH, Choi SH, et al. Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer. Ann Surg Oncol. 2001;8:402-6.
40. Li C, Kim S, Lai J, Oh S, Hyung W, Choi W, et al. Lymph node dissection around the splenic artery and hilum in advanced middle third gastric carcinoma. Eur J Surg Oncol (EJSO). 2009;35:709-14.
41. Lo SS, Wu CW, Shen KH, Hsieh MC, Lui WY. Higher morbidity and mortality after combined total gastrectomy and pancreaticosplenectomy for gastric cancer. World J Surg. 2002;26:678-82.
42. Maehara Y, Oiwa H, Tomisaki S, Sakaguchi Y, Watanabe A, Anai H, et al. Prognosis and surgical treatment of gastric cancer invading the pancreas. Oncology. 2000;59:1-6.
43. Nanthakumaran S, Fernandes E, Thompson A, Rapson T, Gilbert F, Park K. Morbidity and mortality rates following gastric cancer surgery and contiguous organ removal, a population based study. Eur J Surg Oncol. 2005;31:1141-4.
44. Oh SJ, Hyung WJ, Li C, Song J, Kang W, Rha SY, et al. The effect of spleen preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer. J Surg Oncol. 2009;99:275-80.
45. Piso P, Bellin T, Aselmann H, Bektas H, Schlitt H, Klempnauer J. Results of combined gastrectomy and pancreatic resection in patients with advanced primary gastric carcinoma. Dig Surg. 2000;19:281-5.
46. Saji S, Sakamoto J, Teramukai S, Kunieda K, Sugiyama Y, Ohashi Y, et al. Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Surg Today. 1999;29:504-10.
47. Shen JG, Cheong JH, Hyung WJ, Kim J, Choi SH, Noh SH. Adverse effect of splenectomy on recurrence in total gastrectomy cancer patients with perioperative transfusion. Am J Surg. 2006;192:301-5.
48. Shin SH, Jung H, Choi SH, An JY, Choi MG, Noh JH. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer. Ann Surg Oncol. 2009;16:1304-9.
49. Toneri M, Mitsumoto Y, Shimabukuro M, Sunagawa T, Itagaki T, Iida S, et al. Prognosis of patients with gastric carcinoma treated in remote island hospitals in Japan: a multivariable analysis. Anticancer Res. 2006;26:3621.
50. Verlato G, Roviello F, Marchet A, Giacopuzzi S, Marrelli D, Nitti D. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network. Ann Surg Oncol. 2009;16:594-602.
51. Zhang CH, Zhan WH, He YL, Chen C, Huang MJ, Cai SR. Spleen preservation in radical surgery for gastric cardia cancer. Ann Surg Oncol. 2007;14:1312-9.
52. Sano T, Yamamoto S, Sasako M. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan clinical oncology group study JCOG 0110-MF. Jpn J Clin Oncol. 2002;32:363.